Accurant Biotech, Inc.

is an outsourcing organization (CRO) focusing on immune-based and cell-based method development, method validation, and sample analysis in support of clinical and preclinical trials for biological drug development.

Our Core Services

Click and learn about our rich past experiences. We are also expanding our service coverage, currently planning for LC-MS and NGS (next generation sequencing).
Biomarker

Bio Analysis

RO

CMC

CLIA

CLIA

Our Main Platform

Click and learn about our platforms and what we have been achieved.

Protein Platform

LEARN MORE >

Cell Platform

LEARN MORE >

Gene Platform

LEARN MORE >

Tissue Platform

LEARN MORE >

Luminex

MSD

ID5

I3X

Leica Bond Rx

Microtome

Antigen Retriever

Dako Autostainer 48

Tecan 200

Benchsmart 96

Bead Blaster 24

KingFisher

SCIEX TRIPLE QUAD

EXIONLC 2.0

BD FACS Lyric

PharmaEven

QuantStudio5

QX200

Universal M2

Blog

The Method of Improving Drug Tolerance in The ADA Testing Process

Almost all biopharmaceutical products will cause a certain anti-drug antibody (ADA) response after entering the body, which refers to immune response. ADA may affect or change the pharmacodynamic effect between the therapeutic protein and its target. Its...

The Application of Minimum Required Dilution (MRD) in ADA Methods

Minimum Required Dilution (MRD) is used in almost all PK and ADA (including Biomarker and Nab) methods. Usually, all samples in an analysis plate, including standard curve points, quality control samples, and unknown samples, will be diluted multiple folds in the...